Objective: To identify single-nucleotide polymorphisms (SNPs) associated with risk and age at onset of Alzheimer disease (AD) in a genomewide association study of 469 438 SNPs.
Design: Case-control study with replication.
Setting: Memory referral clinics in Canada and the United Kingdom.